Fisogatinib (Standard)
Fisogatinib (Standard) is the analytical standard of Fisogatinib. This product is intended for research and analytical applications. Fisogatinib (BLU-554) is a potent, highly selective and orally active fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 5 nM. Fisogatinib has significant anti-tumor activity in models of hepatocellular carcinoma (HCC) that are dependent on FGFR4 signalling[1][2].
Product Specifications
CAS Number
1707289-21-1
Target
FGFR; Reference Standards
Related Pathways
Others; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
C=CC(N[C@@H]1[C@H](NC2=NC=C3C=C(C4=C(Cl)C(OC)=CC(OC)=C4Cl)C=CC3=N2)COCC1)=O
Molecular Formula
C24H24Cl2N4O4
Molecular Weight
503.38
References & Citations
[1]Dogan-Topal B, et al. Quantification of FGFR4 inhibitor BLU-554 in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Mar 15;1110-1111:116-123.|[2]Richard Kim, et al. First-in-human study of BLU-554, a potent, highly selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation. EJC. December 2016, Volume 69, Supplement 1, Page S41.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7096123 Inquire
Recombinant Human Nuclear envelope pore membrane protein POM 121 (POM121) , partial
Sign In for Pricing
View Details MBS7152986 Inquire
Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate OYI)(HIV-1) VPR Polyclonal Antibody
Sign In for Pricing
View Details